This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

October 26, 2020

Study Completion Date

April 5, 2021

Conditions

SARS-CoV-2 Infection

Interventions

BIOLOGICAL

CT-P59

administered

Trial Locations (1)

Incheon Medical Center, Incheon